DPP4 and inflammatory bowel disease: In addition to the potential benefits of using specific probiotics strains to enhance epithelial barrier integrity and modulate immune responses, this review emphasizes the need for developing personalized interventions tailored to patients’ unique DPP4 activity and microbial profile, representing a promising approach for managing IBD.